Bayer CropScience block deal lifts stock before Q1FY27

Stock in focus after a heavy block trade

Bayer CropScience Ltd came into focus after a large block deal drove a sharp jump in trading volumes and a short-term rally in the stock. The activity coincided with a regulatory filing that the company’s board will meet on August 5, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).

The day also mattered for income-focused investors because the company had earlier communicated the record date for a final dividend of Rs 60 per share for FY 2025-26. With the record date also set as August 5, 2026, the upcoming board meeting and the shareholder process around the dividend remain key near-term events.

Price snapshot: BSE and NSE moves on August 3

During trade on August 3, 2026, the stock was quoted higher on both exchanges based on the live ticks cited. On BSE at 15:55, the price was Rs 4,289, up Rs 56.10 (1.32%) from the previous close of Rs 4,232.90. On NSE at 15:57, the price was Rs 4,303.30, up Rs 68.91 (1.63%) from the previous close of Rs 4,234.40.

The intraday range shown for the session included a move up to around Rs 4,319.90 on BSE and Rs 4,324.00 on NSE. The stock’s moves later cooled from the day’s high after the initial reaction, even as it remained in the green.

Block deal: Rs 2,207.90 crore worth of shares change hands

The key trigger highlighted was a large block transaction on NSE. Data showed that Rs 2,207.90 crore worth of Bayer CropScience shares changed hands in a block deal. A total of 53,54,030 shares were traded at Rs 4,122.30 per share, matching the previous closing price and indicating no discount on the block.

After the block trade, the stock rose 4.52% to hit a high of Rs 4,303.15. It later cut gains and was reported trading at Rs 4,172.65 on BSE, still up 1.35%.

Board meeting on August 5 for Q1 FY27 results

Bayer CropScience informed BSE that its Board of Directors will meet on August 5, 2026. The agenda includes considering and approving the unaudited financial results for the quarter ended June 30, 2026.

This clarifies the immediate timeline for the Q1 FY27 announcement because the board meeting date serves as the decision point for approval and filing. For investors tracking seasonal trends in the agri-input cycle, Q1 (April to June) often captures a key part of pre-monsoon and early monsoon demand in several product categories.

Dividend update: final dividend of Rs 60 per share

The company had earlier said the board meeting held on May 26, 2026 recommended a final dividend of Rs 60 per share for FY 2025-26, subject to shareholder approval at the forthcoming AGM. It also communicated that the record date for the final dividend is August 5, 2026.

In its financial disclosure referenced in the provided text, the recommended final dividend aggregates to Rs 269.7 crore for 44,942,092 equity shares of Rs 10 each. The sequence now hinges on the shareholder approval process and related corporate action timelines.

What analysts are flagging for Q1 FY27

Kotak Institutional Equities said in a Q1 results preview that Bayer’s Q1 FY27 performance could be weighed down by the late arrival of monsoon rains and by a shift in farmer sentiment away from corn hybrid seeds. The note added that corn hybrid seeds typically account for around a quarter of Q1 revenues.

Kotak projected a 5% year-on-year decline in revenues and a 2.3% year-on-year decline in EBITDA, while assuming a slight recovery in margins versus the depressed base of last year. The brokerage projected a 7.7% year-on-year decline in net income. It has an ‘Add’ rating on the stock with a target price of Rs 4,820.

Antique Stock Broking has a ‘Hold’ rating with a target price of Rs 4,900.

Street estimates and tracking ranges cited in the data

The content also carried a separate estimate band for Q1 FY27. The revenue estimate range cited was Rs 2,091 to Rs 2,406 crore, with a PAT estimate range of Rs 270 to Rs 343 crore. It also referenced an analyst target range of roughly Rs 4,620 to Rs 5,032 in one place, and a 12-month target tracking range of Rs 4,867 to Rs 5,445 in another.

These are third-party estimates and ranges in the provided material, not company guidance. Still, they set expectations around the August 5 board meeting outcome.

Recent financial track record: Q4 FY26 and FY26

The company’s May 26, 2026 update included Q4 FY26 and full-year FY26 performance. Revenue from operations for Q4 FY26 was Rs 1,100.8 crore, compared with Rs 1,106.2 crore in Q3 FY26 and Rs 1,046.4 crore in Q4 FY25. For FY26, revenue stood at Rs 5,675.0 crore, up from Rs 5,473.4 crore in FY25.

For profitability, the same update cited Q4 FY26 net profit of Rs 162.1 crore and FY26 net profit of Rs 689.2 crore. Basic and diluted EPS for FY26 was Rs 153.35 versus Rs 126.38 in FY25.

Market impact: why the block deal and dates matter

A block deal of more than Rs 2,200 crore can shift near-term liquidity and price discovery, even when executed at the prior close. The fact that the block was done without a discount suggests the transaction was absorbed at prevailing levels, which can influence sentiment for a stock with a large market capitalisation.

Separately, the August 5 board meeting brings two event anchors close together: the Q1 FY27 results approval and the dividend record date for the final dividend of Rs 60 per share. For investors, that combination can concentrate attention on filings, corporate action schedules, and how Q1 demand patterns played out amid monsoon timing.

Key numbers at a glance

Financial highlights mentioned in the disclosures

What to watch next

The next clear event is the August 5, 2026 board meeting and the filing of unaudited Q1 FY27 numbers. Investors will also track the final dividend process, including shareholder approval at the AGM and the corporate action timeline linked to the record date.

Analyst commentary highlighted monsoon timing and corn seed demand as important variables in Q1, so management commentary alongside the quarterly filing will be watched for product and season cues.

Conclusion

Bayer CropScience’s stock saw a sharp move after a large, no-discount NSE block deal, while the company also set August 5 as the date for approving Q1 FY27 results. The same date is also the record date for the proposed final dividend of Rs 60 per share, keeping corporate filings and shareholder actions in focus over the next few sessions.